LINVOSELTAMAB in patients with relapsed/refractory myeloma | Suzanne Lentzsch MD, PhD | EHA 2024

Sdílet
Vložit
  • čas přidán 20. 06. 2024
  • Dr. Suzanne Lentzsch shares data about upcoming bispecific antibodies.
    The HealthTree Foundation for Multiple Myeloma brings information from the experts to the patients! Learn more at www.healthtree.org/myeloma/co...
    Donate to the HealthTree Foundation for Multiple Myeloma or learn more about additional myeloma support we offer here: give.healthtree.org/campaign/...
    HealthTree Cure Hub helps you find your best treatment options and accelerate a cure for multiple myeloma. Join today at www.healthtree.org/
    Follow HealthTree:
    healthtreeformm
    healthtreeformultiplemyeloma
    instragram.com/healthtreeformultiplemyeloma
  • Věda a technologie

Komentáře •